Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07484685Not ApplicableRecruiting

Reduced Time Interval for Implant Placement After Extraction Socket Preservation Using the Vega Plus Implants

Role: collaborator

NCT07533110Phase 4Recruiting

Evaluation Of The Success Rate of NOVAMag® SHIELD

Role: collaborator

NCT06819995Not ApplicableRecruiting

Accuracy of Static Guided Implant Surgery: 3D-printed vs Milled Surgical Guides

Role: collaborator

NCT05592327Not ApplicableUnknown

Citric Acid Passivation on Implant Abutments for the Prevention of Peri-implant Disease

Role: collaborator

All 4 trials loaded